Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Bladder Cancer, Cisplatin-based Chemotherapy

Cora Sternberg

MD

🏢Weill Cornell Medicine, NewYork-Presbyterian Hospital🌐USA

Clinical Director, Englander Institute for Precision Medicine

72
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Cora Sternberg is a legendary figure in bladder cancer who co-developed the MVAC chemotherapy regimen that became a standard of care for metastatic urothelial carcinoma for decades. Her research shaped the platinum-based chemotherapy landscape in bladder cancer and contributed to understanding dose-dense MVAC with growth factor support. She has been a pioneer in bladder cancer clinical research and advocacy. Her decades of contributions to the field have earned her worldwide recognition as a leading authority in urothelial oncology.

Share:

🧪Research Fields 研究领域

MVAC bladder cancer
cisplatin combination chemotherapy
advanced urothelial cancer
methotrexate vinblastine adriamycin
bladder cancer clinical research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Cora Sternberg 的研究动态

Follow Cora Sternberg's research updates

留下邮箱,当我们发布与 Cora Sternberg(Weill Cornell Medicine, NewYork-Presbyterian Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment